PSORIASIS Is ustekinumab superior to etanercept for psoriasis?

被引：6

作者：

Kuhn, Annegret ^{[1
]}

Luger, Thomas A. ^{[1
]}

机构：

[1] Univ Munster, Dept Dermatol, D-48149 Munster, Germany

来源：

NATURE REVIEWS RHEUMATOLOGY | 2010年 / 6卷 / 09期

关键词：

INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; TNF INHIBITION; TRIAL; EFFICACY; SAFETY;

D O I：

10.1038/nrrheum.2010.134

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Both etanercept and ustekinumab have been shown to be strikingly effective in patients with psoriasis. A phase III trial comparing these two biologic agents for the treatment of moderate-to-severe psoriasis found that ustekinumab was superior to high-dose etanercept over a 12-week period; however, several questions remain to be addressed.

引用

页码：500 / 501

页数：3

共 50 条

[1] Is ustekinumab superior to etanercept for psoriasis?
Annegret Kuhn
Thomas A. Luger
Nature Reviews Rheumatology, 2010, 6 : 500 - 501
[2] Stelara (Ustekinumab) Versus Etanercept for Psoriasis
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (05) : 572 - 572
[3] Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis
Uhlenhake, Elizabeth E.
Feldman, Steven R.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (07) : 1105 - 1112
[4] Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Griffiths, Christopher E. M.
Strober, Bruce E.
van de Kerkhof, Peter
Ho, Vincent
Fidelus-Gort, Roseanne
Yeilding, Newman
Guzzo, Cynthia
Xia, Yichuan
Zhou, Bei
Li, Shu
Dooley, Lisa T.
Goldstein, Neil H.
Menter, Alan
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (02): : 118 - 128
[5] COST EFFECTIVENESS OF TREATMENT WITH ETANERCEPT OR USTEKINUMAB FOR MODERATE TO SEVERE PSORIASIS
Villacorta, R.
Hay, J.
Messali, A.
VALUE IN HEALTH, 2012, 15 (04) : A103 - A103
[6] Sacroiliitis in a psoriasis patient after switching from etanercept to ustekinumab
Vilaca, Susana
Torres, Tiago
Selores, Manuela
EUROPEAN JOURNAL OF DERMATOLOGY, 2013, 23 (06) : 897 - 898
[7] COST-EFFECTIVENESS OF USTEKINUMAB VS ETANERCEPT FOR SEVERE PSORIASIS
Sura, M.
Avxentyeva, M.
Omelyanovsky, V
Zorin, N.
Hailov, P.
VALUE IN HEALTH, 2011, 14 (07) : A506 - A506
[8] Etanercept plus narrowband UVB phototherapy is superior to etanercept monotherapy of psoriasis
Gambichler, T.
Kreuter, A.
Scola, N.
Tigges, C.
Skrygan, M.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 45 - 46
[9] Risk of infection in children with psoriasis receiving treatment with ustekinumab, etanercept, or methotrexate
Schneeweiss, Maria
Savage, Timothy J.
Wyss, Richard
Kirchgesner, Julien
Jin, Yinzhu
York, Cassandra
Merola, Joseph F.
Schneeweiss, Sebastian
Glynn, Robert
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 469 - 469
[10] Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria
Richter, Leo
Vujic, Igor
Sesti, Alma
Monshi, Babak
Sanlorenzo, Martina
Posch, Christian
Rappersberger, Klemens
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 (03): : 309 - 317

← 1 2 3 4 5 →